Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
In recent years, several associations between common chronic human disorders and altered gut microbiome composition and function have been reported. In most of these reports, treatment regimens were not controlled for and conclusions could thus be confounded by the effects of various drugs on the microbiota, which may obscure microbial causes, protective factors or diagnostically relevant signals. Our study addresses disease and drug signatures in the human gut microbiome of type 2 diabetes mellitus (T2D). Two previous quantitative gut metagenomics studies of T2D patients that were unstratified for treatment yielded divergent conclusions regarding its associated gut microbial dysbiosis. Here we show, using 784 available human gut metagenomes, how antidiabetic medication confounds these results, and analyse in detail the effects of the most widely used antidiabetic drug metformin. We provide support for microbial mediation of the therapeutic effects of metformin through short-chain fatty acid production, as well as for potential microbiota-mediated mechanisms behind known intestinal adverse effects in the form of a relative increase in abundance of Escherichia species. Controlling for metformin treatment, we report a unified signature of gut microbiome shifts in T2D with a depletion of butyrate-producing taxa. These in turn cause functional microbiome shifts, in part alleviated by metformin-induced changes. Overall, the present study emphasizes the need to disentangle gut microbiota signatures of specific human diseases from those of medication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“patient treatment with the drug metformin, a variable that subjects had not been stratified for previously, constituted the main determinant of microbial signatures in diabetic cohorts [62].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [62]
In the citing paper
“This action is an important determinant for the anti-hyperglycemic therapeutic effects, the gastrointestinal side effects and possibly the anti-aging effects of metformin (88, 89).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [88]
In the citing paper
“As for C. elegans, metformin use in humans will change the microbiome.”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [88]
In the citing paper
“Studies comparing individuals with T2D treated or not with metformin identified a higher level of E. coli and a lower level of Intestinibacter in the metformin-treated individuals, while confirming reduced levels of butyrate-producing bacteria such as Roseburia spp., F. prausnitzii, and unnamed Clostridiales in the untreated individuals compared to healthy controls5, 6, 34, 35.”
From The gut microbiome in atherosclerotic cardiovascular disease (2017) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
The SILVA ribosomal RNA gene database project: improved data processing and web-based tools
Quast, C., Pruesse, E., Yilmaz, P., Gerken, J., Schweer, T., Yarza, P., Peplies, J., & Glöckner, F. O. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1219 · Cited by 33,055
Regularization Paths for Generalized Linear Models via Coordinate Descent
Friedman, J., Hastie, T., & Tibshirani, R. (2010) · Journal of Statistical Software · doi:10.18637/jss.v033.i01 · Cited by 19,927
UPARSE: highly accurate OTU sequences from microbial amplicon reads
Edgar, R. C. (2013) · Nature Methods · doi:10.1038/nmeth.2604 · Cited by 16,707
FLASH: fast length adjustment of short reads to improve genome assemblies
Magoč, T., & Salzberg, S. L. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr507 · Cited by 15,366
UCHIME improves sensitivity and speed of chimera detection
Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C., & Knight, R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr381 · Cited by 15,114
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
A new method for non-parametric multivariate analysis of variance
Anderson, M. J. (2001) · Austral Ecology · doi:10.1111/j.1442-9993.2001.01070.pp.x · Cited by 13,828
Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences
Li, W., & Godzik, A. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl158 · Cited by 11,410
VEGAN, a package of R functions for community ecology
Dixon, P. (2003) · Journal of Vegetation Science · doi:10.1111/j.1654-1103.2003.tb02228.x · Cited by 6,824
Cited by
Items 701–800 of 1,006
A system biology perspective on environment–host–microbe interactions
Chen, L., Garmaeva, S., Zhernakova, A., Fu, J., & Wijmenga, C. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy137 · Cited by 53
Antidiabetic Drugs in NAFLD: The Accomplishment of Two Goals at Once?
Tacelli, M., Celsa, C., Magro, B., Giannetti, A., Pennisi, G., Spatola, F., & Petta, S. (2018) · Pharmaceuticals · doi:10.3390/ph11040121 · Cited by 51
Inter-kingdom signaling between gut microbiota and their host
Li, Q., Ren, Y., & Fu, X. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03076-7 · Cited by 54
Kayser, B. D., Prifti, E., Lhomme, M., Belda, E., Dao, M. C., Aron‐Wisnewsky, J., Cotillard, A., Kennedy, S., Pons, N., Chatelier, E. L., et al. (2019) · Metabolomics · doi:10.1007/s11306-019-1596-0 · Cited by 53
Self-citationThe Association of Targeted Gut Microbiota with Body Composition in Type 2 Diabetes Mellitus
Hung, W.-C., Hung, W., Tsai, H.-J., Chang, C.-C., Chiu, Y., Hwang, S., Kuo, M., Chen, S., Dai, C., & Tsai, Y. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.51164 · Cited by 53
Vals‐Delgado, C., Alcala-Diaz, J. F., Molina‐Abril, H., Roncero‐Ramos, I., Caspers, M. P. M., Schuren, F. H. J., van den Broek, T. J., Luque, R. M., Pérez‐Martínez, P., Katsiki, N., et al. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.05.001 · Cited by 53
Xi, Y., & Xu, P. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i10.1693 · Cited by 53
The role of lipopolysaccharides in diabetic retinopathy
Qin, X., & Zou, H. (2022) · BMC Ophthalmology · doi:10.1186/s12886-022-02296-z · Cited by 53
Domestic Environment and Gut Microbiota: Lessons from Pet Dogs
Hernandez, J. L., Rhimi, S., Kriaa, A., Mariaule, V., Boudaya, H., Drut, A., Jablaoui, A., Mkaouar, H., Saidi, A., Biourge, V. C., et al. (2022) · Microorganisms · doi:10.3390/microorganisms10050949 · Cited by 52
Short-chain fatty acids as a link between diet and cardiometabolic risk: a narrative review
Birkeland, E., Gharagozlian, S., Valeur, J., & Aas, A. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01803-5 · Cited by 52
Yadav, D., Ghosh, T. S., & Mande, S. S. (2016) · Gut Pathogens · doi:10.1186/s13099-016-0099-z · Cited by 52
Borg, M. J., Bound, M., Grivell, J., Sun, Z., Jones, K. L., Horowitz, M., Rayner, C. K., & Wu, T. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13567 · Cited by 49
Hansen, T. H., Thomassen, M. T., Madsen, M. L., Kern, T., Bak, E. G., Kashani, A., Allin, K. H., Hansen, T. F., & Pedersen, O. B. (2018) · Scientific Reports · doi:10.1038/s41598-018-34761-5 · Cited by 52
Self-citationGut Microbial Predictors of Type 2 Diabetes Remission Following Bariatric Surgery
Davies, N., O'Sullivan, J. M., Plank, L. D., & Murphy, R. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04684-0 · Cited by 52
The Potential Utility of Prebiotics to Modulate Alzheimer’s Disease: A Review of the Evidence
Kang, J. W., & Zivkovic, A. M. (2021) · Microorganisms · doi:10.3390/microorganisms9112310 · Cited by 52
Metformin Mitigates Sepsis-Related Neuroinflammation via Modulating Gut Microbiota and Metabolites
Zhao, H., Lyu, Y., Zhai, R., Sun, G., & Ding, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.797312 · Cited by 52
Effects of Oral Glucose-Lowering Agents on Gut Microbiota and Microbial Metabolites
Wang, D., Liu, J. Y., Zhou, L., Zhang, Q., Li, M., & Xiao, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.905171 · Cited by 52
Repurposing Metformin in Nondiabetic People With HIV: Influence on Weight and Gut Microbiota
Isnard, S., Lin, J., Fombuena, B., Ouyang, J., Varin, T. V., Richard, C., Marette, A., Ramendra, R., Planas, D., Raymond Marchand, L., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa338 · Cited by 51
Wu, L., Xie, X., Li, Y., Liang, T., Zhong, H., Ma, J., Yang, L., Yang, J., Li, L., Yu, X., et al. (2021) · Antibiotics · doi:10.3390/antibiotics10081006 · Cited by 51
Li, H., & Li, C. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1184734 · Cited by 51
Jacob, S., Dötsch, A., Knoll, S., Köhler, H., Rogall, E. T., Stoll, D., Tisler, S., Hühn, C., Schwartz, T., Zwiener, C., et al. (2018) · Environmental Sciences Europe · doi:10.1186/s12302-018-0179-4 · Cited by 51
Kuhn, P. E., Kalariya, H. M., Poulev, A., Ribnicky, D., Jaja-Chimedza, A., Roopchand, D. E., & Raskin, I. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198716 · Cited by 51
Role and effective therapeutic target of gut microbiota in NAFLD/NASH (Review)
Liu, Q., Liu, S., Chen, L., Zhao, Z., Du, S.-X., Dong, Q., Xin, Y., & Xuan, S. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7781 · Cited by 51
Liu, Y., & Lou, X. (2020) · Clinics · doi:10.6061/clinics/2020/e1277 · Cited by 51
Lim, M. Y., Hong, S. P., Kim, B., Ahn, Y., Kim, H., & Nam, Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-58719-8 · Cited by 51
Shi, Y., Li, J., Yang, P., Niu, Z., Li, W., Chen, L., & Gao, L. (2020) · Toxicology Letters · doi:10.1016/j.toxlet.2020.09.018 · Cited by 51
Self-citationHuang, X., Hong, X., Wang, J., Sun, T., Yu, T., Yu, Y., Fang, J., & Xiong, H. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103037 · Cited by 51
Self-citationDebédat, J., Roy, T. L., Voland, L., Belda, E., Alili, R., Adriouch, S., Lassen, P. B., Kasahara, K., Hutchison, E. R., Genser, L., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2050635 · Cited by 51
Harness the functions of gut microbiome in tumorigenesis for cancer treatment
Lee, M. (2021) · Cancer Communications · doi:10.1002/cac2.12200 · Cited by 50
Ni, Y., Zheng, A., Hu, Y., Rong, N., Zhang, Q., Long, W., Yang, S., Nan, S., Zhang, L., Zhou, K., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.959703 · Cited by 50
Exploring the role of gut microbiota in advancing personalized medicine
Huang, G., Khan, R., Zheng, Y., Lee, P.-C., Li, Q., & Khan, I. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1274925 · Cited by 50
Wang, Y., Jia, X., & Cong, B. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1396031 · Cited by 50
Byndloss, M. X., Devkota, S., Duca, F. A., Niess, J. H., Nieuwdorp, M., Orho‐Melander, M., Sanz, Y., Tremaroli, V., & Zhao, L. (2024) · Diabetes Care · doi:10.2337/dci24-0052 · Cited by 50
Metformin Joins Forces with Microbes
Cabreiro, F. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2015.12.012 · Cited by 50
Interpretable and accurate prediction models for metagenomics data
Prifti, E., Chevaleyre, Y., Hanczar, B., Belda, E., Danchin, A., Clément, K., & Zucker, J. (2020) · GigaScience · doi:10.1093/gigascience/giaa010 · Cited by 50
Self-citationWang, L., Yu, X., Xu, X., Ming, J., Wang, Z., Gao, B., Xing, Y., Zhou, J., Fu, J., Liu, T., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.598672 · Cited by 52
Li, X., Zhang, X., Zhang, R., Ni, Z., Elam, E., Thakur, K., Céspedes, C. L., Zhang, J., & Wei, Z. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112235 · Cited by 50
Zhang, Y., Yang, C., Liu, J., Zuo, J., Yan, L., Thring, R. W., Ba, X., Qi, D., Wu, M., Gao, Y., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102481 · Cited by 50
Ezzamouri, B., Rosário, D., Bidkhori, G., Lee, S., Uhlén, M., & Shoaie, S. (2023) · npj Systems Biology and Applications · doi:10.1038/s41540-022-00261-6 · Cited by 50
Why the endothelium? The endothelium as a target to reduce diabetes-associated vascular disease
Triggle, C. R., Ding, H., Marei, I., Anderson, T. J., & Hollenberg, M. D. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0677 · Cited by 49
Type 2 Diabetes and the Microbiome
Barlow, G. M., & Mathur, R. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac184 · Cited by 49
Gu, J.-F., Su, S., Guo, J.-M., Zhu, K. Y., Zhao, M., & Duan, J. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.06.010 · Cited by 49
Han, K., Bose, S., Wang, J., Lim, S.-K., Chin, Y., Kim, Y., Choi, H., & Kim, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182467 · Cited by 49
Self-citationMetagenomic analysis of gut microbial communities from a Central Asian population
Kushugulova, A., Forslund, S. K., Costea, P. I., Kozhakhmetov, S., Khassenbekova, Z., Urazova, M., Nurgozhin, T., Zhumadilov, Z., Benberin, V., Driessen, M., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-021682 · Cited by 47
Self-citationThenappan, T., Khoruts, A., Chen, Y., & Weir, Ε. K. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00416.2019 · Cited by 49
Nakajima, H., Takewaki, F., Hashimoto, Y., Kajiyama, S., Majima, S., Okada, H., Senmaru, T., Ushigome, E., Nakanishi, N., Hamaguchi, M., et al. (2020) · Life · doi:10.3390/life10090195 · Cited by 49
Bakır-Güngör, B., Bulut, O., Jabeer, A., Nalbantoğlu, Ö. U., & Yousef, M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.628426 · Cited by 49
Gut microbiota and vitamin status in persons with obesity: A key interplay
Voland, L., Roy, T. L., Debédat, J., & Clément, K. (2021) · Obesity Reviews · doi:10.1111/obr.13377 · Cited by 49
Zhang, K., Zhang, Q., Qiu, H., Ma, Y., Hou, N., Zhang, J., Kan, C., Han, F., Sun, X., & Shi, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37609 · Cited by 48
Microbial Impact on Host Metabolism: Opportunities for Novel Treatments of Nutritional Disorders?
Plovier, H., & Cani, P. D. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0002-2016 · Cited by 41
Probiotic strains and mechanistic insights for the treatment of type 2 diabetes
Hampe, C. S., & Roth, C. L. (2017) · Endocrine · doi:10.1007/s12020-017-1433-z · Cited by 49
Network Analysis as a Grand Unifier in Biomedical Data Science
McGillivray, P. D., Clarke, D., Meyerson, W. U., Zhang, J., Lee, D., Gu, M., Kumar, S., Zhou, H., & Gerstein, M. (2018) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-080917-013444 · Cited by 49
Hoel, H., Hove‐Skovsgaard, M., Hov, J. R., Gaardbo, J. C., Holm, K., Kummen, M., Rudi, K., Nwosu, F. C., Valeur, J., Gelpi, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-25168-3 · Cited by 48
Conducting metagenomic studies in microbiology and clinical research
Martin, T. C., Visconti, A., Spector, T. D., & Falchi, M. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9209-9 · Cited by 48
Wu, F., Yang, L., Islam, M. T., Jasmine, F., Kibriya, M. G., Nahar, J., Barmon, B., Parvez, F., Sarwar, G., Ahmed, A., et al. (2018) · Environment International · doi:10.1016/j.envint.2018.11.049 · Cited by 48
Guo, M., Chen, J., Li, Q., Fu, Y., Fan, G., Ma, J., Peng, L., Zeng, L., Chen, J., Wang, Y., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03138 · Cited by 48
Microbiome Alteration in Type 2 Diabetes Mellitus Model of Zebrafish
Okazaki, F., Zang, L., Nakayama, H., Chen, Z., Gao, Z.-J., Chiba, H., Hui, S., Aoki, T., Nishimura, N., & Shimada, Y. (2019) · Scientific Reports · doi:10.1038/s41598-018-37242-x · Cited by 48
Routy, J., Isnard, S., Mehraj, V., Ostrowski, M., Chomont, N., Ancuța, P., Ponte, R., Planas, D., Dupuy, F. P., & Angel, J. B. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-028444 · Cited by 48
Impact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome?
Debédat, J., Amouyal, C., Aron‐Wisnewsky, J., & Clément, K. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00738-3 · Cited by 48
Dong, T. S., Chang, H.-H., Hauer, M., Lagishetty, V., Katzka, W. R., Rozengurt, E., Jacobs, J. P., & Eibl, G. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00170.2019 · Cited by 48
Wang, H., Gou, W., Su, C., Du, W., Zhang, J., Miao, Z., Xiao, C., Jiang, Z., Wang, Z., Fu, Y., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05687-5 · Cited by 48
Interplays between drugs and the gut microbiome
Wan, Y., & Zuo, T. (2022) · Gastroenterology report · doi:10.1093/gastro/goac009 · Cited by 48
Caminero, A., Tropini, C., Valles‐Colomer, M., Shung, D. L., Gibbons, S. M., Surette, M. G., Sokol, H., Tomeo, N. J., Alenghat, T., Awoniyi, M., et al. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01100-9 · Cited by 47
Pedersen, C., Ijaz, U. Z., Gallagher, E., Horton, F., Ellis, R. J., Jaiyeola, E., Duparc, T., Russell-Jones, D. L., Hinton, P. J., Cani, P. D., et al. (2018) · Physiological Reports · doi:10.14814/phy2.13649 · Cited by 47
Put “gender glasses” on the effects of phenolic compounds on cardiovascular function and diseases
Campesi, I., Marino, M., Cipolletti, M., Romani, A., & Franconi, F. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1695-0 · Cited by 49
Adeshirlarijaney, A., Zou, J., Tran, H. Q., Chassaing, B., & Gewirtz, A. T. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00245.2019 · Cited by 46
Zheng, Y., Gou, X., Zhang, L., Gao, H., Wei, Y., Yu, X., Pang, B., Tian, J., Tong, X., & Li, M. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00360 · Cited by 47
Huang, Z., Zhao, L., Zhu, F.-R., Liu, Y., Xiao, J.-Y., Chen, Z., Lv, X., Huang, Y., & Liu, B. (2022) · Foods · doi:10.3390/foods11070974 · Cited by 47
The gut microbiota in kidney disease
Pluznick, J. L. (2020) · Science · doi:10.1126/science.abd8344 · Cited by 47
From hype to hope: Considerations in conducting robust microbiome science
McGuinness, A. J., Stinson, L. F., Snelson, M., Loughman, A., Stringer, A. M., Hannan, A. J., Cowan, C. S. M., Jama, H. A., Caparros-Martin, J. A., West, M. L., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.09.022 · Cited by 46
Role of Gut Microbial Metabolites in Cardiovascular Diseases—Current Insights and the Road Ahead
Datta, S., Pasham, S., Sandeep, I. S., Boini, K. M., & Koka, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810208 · Cited by 46
Li, P., Li, M., & Chen, W. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2489074 · Cited by 48
The gut microbiome and frailty
Piggott, D. A., & Tuddenham, S. (2020) · Translational research · doi:10.1016/j.trsl.2020.03.012 · Cited by 46
Lee, Y., Kim, A. H., Kim, E., Lee, S., Yu, K., Jang, I., Chung, J., & Cho, J. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108985 · Cited by 46
Tierney, B. T., Tan, Y., Yang, Z., Shui, B., Walker, M. J., Kent, B. M., Kostic, A. D., & Patel, C. J. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001556 · Cited by 46
C. elegans: A biosensor for host–microbe interactions
Backes, C., Martínez‐Martínez, D., & Cabreiro, F. (2021) · Lab Animal · doi:10.1038/s41684-021-00724-z · Cited by 45
Bataineh, M. T. A., Künstner, A., Dash, N. R., AlSafar, H. S., Ragab, M., Schmelter, F., Sina, C., Busch, H. S., & Ibrahim, S. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-45066-7 · Cited by 45
The Gut Microbiota-Related Antihyperglycemic Effect of Metformin
Szymczak-Pajor, I., Drzewoski, J., Kozłowska, M., Krekora, J., & Śliwińska, A. (2025) · Pharmaceuticals · doi:10.3390/ph18010055 · Cited by 46
Microbiome sequencing: challenges and opportunities for molecular medicine
Clavel, T., Lagkouvardos, I., & Hiergeist, A. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2016.1184574 · Cited by 46
Schommers, P., Thurau, A., Bultmann-Mellin, I., Guschlbauer, M., Klatt, A. R., Rozman, J., Klingenspor, M., de Angelis, M. H., Alber, J., Gründemann, D., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.05.002 · Cited by 45
Increase in clinically recorded type 2 diabetes after colectomy
Jensen, A. B., Sørensen, T. I. A., Pedersen, O. B., Jess, T., Brunak, S., & Allin, K. H. (2018) · eLife · doi:10.7554/elife.37420 · Cited by 45
Self-citationKishikawa, T., Ogawa, K., Motooka, D., Hosokawa, A., Kinoshita, M., Ken, S., Yamamoto, K., Masuda, T., Matsumoto, Y., Nii, T., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.585973 · Cited by 45
Diener, C., Reyes‐Escogido, M. D. L., Jiménez-Ceja, L. M., Matus, M. G., Navarro, C. M. G., Chu, N. D., Zhong, V., Tejero, M. E., Alm, E. J., Reséndis-Antonio, O., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.602326 · Cited by 45
Compositional and functional alterations of gut microbiota in patients with stroke
Xu, D., Wang, K., Yuan, L., Li, H., Xu, Y., Wei, L., Chen, L., Jin, K., & Lin, Q. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.08.045 · Cited by 45
Lu, Y., Xing, S., He, L., Li, C., Wang, X., Zeng, X., & Dai, Y. (2022) · Foods · doi:10.3390/foods11193063 · Cited by 45
Shared Dysregulation of Homeostatic Brain-Body Pathways in Depression and Type 2 Diabetes
Hoogendoorn, C. J., Delgado, J. F. R., & Gonzalez, J. S. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0923-y · Cited by 45
Balvers, M., Deschasaux, M., van den Born, B. H., Zwinderman, A. H., Nieuwdorp, M., & Levin, E. (2021) · Nutrients · doi:10.3390/nu13093289 · Cited by 44
Zhou, Y., Suo, W., Zhang, X., Liang, J., Zhao, W., Wang, Y., Li, H., & Ni, Q. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115669 · Cited by 44
Song, H., Xue, H., Zhang, Z., Wang, J., Li, A., Zhang, J., Luo, P., Zhan, M., Zhou, X., Chen, L., et al. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c04665 · Cited by 44
Self-citationNutrients in Energy and One-Carbon Metabolism: Learning from Metformin Users
Luciano‐Mateo, F., Hernández‐Aguilera, A., Cabré, N., Camps, J., Fernández‐Arroyo, S., López‐Miranda, J., Menéndez, J. A., & Joven, J. (2017) · Nutrients · doi:10.3390/nu9020121 · Cited by 44
Antibacterial Effects of Antiretrovirals, Potential Implications for Microbiome Studies in HIV
Shilaih, M., Angst, D. C., Marzel, A., Bonhoeffer, S., Günthard, H. F., & Kouyos, R. D. (2017) · Antiviral Therapy · doi:10.3851/imp3173 · Cited by 44
Dao, M. C., Sokolovska, N., Brazeilles, R., Affeldt, S., Pelloux, V., Prifti, E., Chilloux, J., Verger, E. O., Kayser, B. D., Aron‐Wisnewsky, J., et al. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2018.01958 · Cited by 45
Self-citationLi, Q., Peng, W., Wu, J., Wang, X., Ren, Y., Li, H., Peng, Y., Tang, X., & Fu, X. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1626192 · Cited by 44
Shoshan‐Barmatz, V., Anand, U., Crystal, E. N., Carlo, M. D., & Shteinfer‐Kuzmine, A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.730048 · Cited by 44
Si, J., Lee, G., You, H. J., Joo, S. K., Lee, D. H., Ku, B. J., Park, S., Kim, W. K., & Ko, G. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.10.032 · Cited by 44
Urolithins: Diet-Derived Bioavailable Metabolites to Tackle Diabetes
Raimundo, A., Ferreira, S., Tomás-Barberán, F. A., dos Santos, C. N., & Menezes, R. (2021) · Nutrients · doi:10.3390/nu13124285 · Cited by 44
Chen, K., Wei, X., Kortesniemi, M. K., Pariyani, R., Zhang, Y., & Yang, B. (2022) · Food Research International · doi:10.1016/j.foodres.2022.110978 · Cited by 44
Feng, X., Wang, D., Hu, L., Lu, H., Ling, B., Huang, Y., & Jiang, Q. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.962775 · Cited by 44
Huang, P., Wang, X., Wang, S., Wu, Z., Zhou, Z., Shao, G., Ren, C., Kuang, M., Zhou, Y., Jiang, A., et al. (2022) · Current Research in Food Science · doi:10.1016/j.crfs.2022.08.011 · Cited by 43
“Also, the bacteria and its metabolite like SCFAs increase Treg cell number in lamina propria of intestinal mucosa which can maintain the function of immunity normal and prevent excessive immune response.”
InfluentialGut microbiome and amyotrophic lateral sclerosis: a systematic review of current evidence
Sun, J., Huang, T., Debelius, J. W., & Fang, F. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13336 · Cited by 43
Metadata
- Authors
- MetaHIT consortium, Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., Prifti, E., Vieira-Silva, S., Gudmundsdottir, V., Krogh Pedersen, H., Arumugam, M., Kristiansen, K., Yvonne Voigt, A., Vestergaard, H., Hercog, R., Igor Costea, P., Roat Kultima, J., Li, J., Jørgensen, T., Levenez, F., Dore, J., Bjørn Nielsen, H., Brunak, S., Raes, J., Hansen, T., Wang, J., Dusko Ehrlich, S., Bork, P., & Pedersen, O.
- Affiliations
- Vrije Universiteit Brussel (BE)
- University of Copenhagen (DK)
- Rega Institute for Medical Research (BE)
- European Molecular Biology Laboratory (DE)
- Microbiologie de l’alimentation au service de la santé (FR)
- BGI Group (China) (CN)
- Corresponding author
- Pedersen, Oluf
- ORCID
- Venue
- Nature
- Published
- 2015-12-02
- Volume
- 528
- Issue
- 7581
- Pages
- 262-266
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4681099
- OpenAlex
- W2188930066
- Cited by
- 2,116
- References
- 49
- Citations by year
- 2026: 113 · 2025: 167 · 2024: 212 · 2023: 194 · 2022: 253 · 2021: 270 · 2020: 256 · 2019: 185 · 2018: 197 · 2017: 150 · 2016: 112 · 2015: 3
- FWCI
- 66.83
- Type
- journal article
- Language
- en
- Update notices
- erratum (2017-05-04)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion)
- HAL (submittedVersion, cc-by-nc-nd)
- HAL (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
- Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Funders
- Innovationsfonden
- European Molecular Biology Laboratory
- European Commission (600375, 2007–2013, FP7 2007-2013, HORIZON2020, FP7/2007, 305312, 201052, 261376)
- Agence Nationale de la Recherche (ANR-11-DPBS-0001)
- Lundbeckfonden
- Novo Nordisk
- Göteborgs Universitet
- Copenhagen Graduate School for Nanoscience and Nanotechnology
- Novo Nordisk Foundation Center for Basic Metabolic Research
- H. Lundbeck A/S
- FP7 Ideas: European Research Council (268985)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- type 2 diabetes, gut microbiota, metformin, antidiabetic drugs, dysbiosis, confounding by treatment, short-chain fatty acids, butyrate, Escherichia, metagenome-wide association study
- MeSH terms
- Gastrointestinal Microbiome, Diabetes Mellitus, Type 2, Female, Humans, Hypoglycemic Agents, Male, Metformin, RNA, Ribosomal, 16S, Biodiversity, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.